Evidence map›Paper›PMID 35761911›Full record

ArticleCureus2022

Oral Malignant Melanoma in a Patient With Neurofibromatosis Type 1: An Extremely Rare Association.

Soufiane Berhili, Mohammed Rezzoug, Ahmed Ben Sghier, Mohammed Moukhlissi, Loubna Mezouar

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Malignant Melanoma Associated with Neurofibromatosis Type 1.Internal medicine (Tokyo, Japan) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Soufiane BerhiliFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Mohammed RezzougDepartment of Radiation Oncology, Hassan II Oncology Centre, Mohammed VI University Hospital, Oujda, MAR.
Ahmed Ben SghierDepartment of Radiation Oncology, Hassan II Oncology Centre, Mohammed VI University Hospital, Oujda, MAR.
Mohammed MoukhlissiDepartment of Radiation Oncology, Hassan II Oncology Centre, Mohammed VI University Hospital, Oujda, MAR.
Loubna MezouarDepartment of Radiation Oncology, Hassan II Oncology Centre, Mohammed VI University Hospital, Oujda, MAR.
Premier University · BDRadiation Oncology Institute · USMohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) is a genetic disorder associated with high rates of neural crest-derived tumors, both benign and malignant. Many series have identified cutaneous melanoma as a rare tumor among cancers occurring in individuals with NF1 disease, but the mucosal location has to date never been reported. In this paper, we report an oral melanoma occurring in a patient with NF1 disorder, diagnosed at a locally advanced stage, successfully managed by definitive external beam radiotherapy, along with a comprehensive literature review on the melanoma-NF1 association.

Indexed as

neurofibromatosis type 1oral melanomaradiotherapyrare associationvon recklinghausen disease

Identifiers

PMID35761911
PMCPMC9232212
OpenAlexW4281556621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.